Drug or treatment

Apamistamab clinical trials

• 2Clinical trials
• 1Country

All recruiting trials (2)

• 131I-apamistamab conditioning for stem cell transplant in advanced sickle cell disease

  This trial tries to see if a targeted radioactive antibody (131I-apamistamab) can be used as the pre-transplant conditioning to prepare people aged 12–50 with advanced sickle cell disease and an HLA-matched sibling donor for an allogeneic stem cell transplant.

  Recruiting Phase 1 Columbia University · New York, New York · NCT07015684

• Treatment for relapsed or refractory diffuse large B-cell lymphoma using IOMAB-ACT and CAR-T cell therapy

  This study is testing a new treatment combining a special radioactive drug and CAR-T cell therapy to see if it helps people with relapsed or hard-to-treat diffuse large B-cell lymphoma.

  Recruiting Phase 1/2 University of Texas Southwestern Medical Center · Dallas, Texas · NCT06768905

Quick answers

How many clinical trials of Apamistamab are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →